| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |